Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.3 was added and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These changes do not affect the study history content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page shows a new site revision tag, updating from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe site-wide operating-status notice regarding government funding has been removed from the page.SummaryDifference0.5%

- Check62 days agoChange DetectedThe screenshots show a redesigned header and revised layout on the Record History page, while the version list and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference11%

- Check98 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.SummaryDifference0.3%

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.